SDS Optic projects and granyts subpage

Projects and grants

Our team is leveraging photonics and molecular biology to develop novel solutions in diagnostics

LAWP 1.3 Research and innovation in the business sector – easily integrable sensors for detection

Project title: Development of technology for manufacturing easily integrable sensors for detecting physical, chemical, and biological signals. Beneficiary: SDS Optic S.A.

Project Objective: The goal of this research project is to develop an advanced manufacturing technology for easily integrable sensors capable of simultaneously detecting signals from physical, chemical, and biological factors. The project's innovation lies in the creation of universal sensors that can be integrated with various platforms, such as optical fibers, lenses, or glass surfaces.

Learn more

LAWP 1.3 Research and innovation in the business sector – multilayer multifunctional coating

Project title: Development and implementation of a multi-layer multifunctional coating for deposition on glass surfaces/lenses in the company's operations. Beneficiary: SDS Optic S.A.

Project Objective: The research and development project by SDS Optic S.A. focuses on the development of technologically advanced multifunctional coatings for deposition on glass surfaces/lenses. The main goal is to create coatings with optical, chemical, and biocidal properties.

Learn more

LAWP 1.2 Infrastructure – Sensor Optimization for Medical Applications

Project title: Purchase of equipment for conducting research and development work on optimizing a sensor for medical applications, which is part of a proprietary microsensor for disease diagnostics. Beneficiary: SDS Optic S.A.

The goal of the Project is to acquire optoelectronic (photonic) devices for conducting research and development work aimed at optimizing the sensor that is part of the proprietary inPROBE microprobe technology platform, owned by SDS Optic S.A.

Learn more

Horrizon 2020

Horizon 2020 is the largest EU research and innovation funding program, with a budget of 80 billion EUR. The revolutionary Omi-Probe microprobe for in-body breast cancer diagnostics received a record 4 million EUR from the Horizon 2020 program, surpassing 1,500 competitors from across Europe. SDS Optic allocated the funds for R&D development, clinical trials, certification, approvals, and commercialization.

We Care About Your Privacy

SDS Optic S.A. uses cookies to improve and customize users experience on our website. By selecting 'Accept', you consent to the use of all cookies that gather and use information about your interactions with our site to provide personalized content and enhance your digital experience. Please read our Privacy Policy for more information.